| scholarly article | Q13442814 |
| P50 | author | Kevin Kemp | Q57001285 |
| David C Wraith | Q59690835 | ||
| Neil Scolding | Q79652575 | ||
| P2093 | author name string | A. Wilkins | |
| D. Gordon | |||
| E. Mallam | |||
| J. Uney | |||
| E. Hartfield | |||
| P2860 | cites work | Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction | Q24534652 |
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant | Q28210402 | ||
| Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick type C mice | Q80994181 | ||
| Autologous mesenchymal stem cell transplantation in stroke patients | Q81803888 | ||
| Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord | Q83297845 | ||
| Mesenchymal stem cells | Q29619804 | ||
| Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains | Q30885823 | ||
| Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion | Q33329509 | ||
| Cytokines in CNS disorders: neurotoxicity versus neuroprotection. | Q34015531 | ||
| Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells | Q34371634 | ||
| Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation | Q34503325 | ||
| Autologous mesenchymal bone marrow stem cells: practical considerations. | Q34695286 | ||
| Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats | Q35039921 | ||
| Treatment of neural injury with marrow stromal cells | Q35172499 | ||
| Adult stem cells--reprogramming neurological repair? | Q35832764 | ||
| IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE | Q36103132 | ||
| Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo. | Q36294165 | ||
| cDNA cloning and characterization of three genes uniquely expressed in cerebellum by Purkinje neurons | Q36438670 | ||
| Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury | Q36866091 | ||
| Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation | Q40600413 | ||
| Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 | ||
| Stromal cells retard the differentiation of CD34(+)CD38(low/neg) human primitive progenitors exposed to cytokines independent of their mitotic history | Q40832796 | ||
| Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration | Q42828754 | ||
| Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration | Q43195511 | ||
| Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness | Q45879145 | ||
| Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. | Q46979432 | ||
| Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells | Q47661065 | ||
| The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system | Q47861473 | ||
| Stem cell fusion in the brain | Q48156706 | ||
| Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival | Q48371412 | ||
| Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | Q48497239 | ||
| A cytochemical and autoradiographic study of nuclear DNA in mouse Purkinje cells | Q48664059 | ||
| Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion | Q49047090 | ||
| Tetraploid DNA Content of Purkinje Neurons of Human Cerebellar Cortex | Q51192080 | ||
| Induction and survival of binucleated Purkinje neurons by selective damage and aging. | Q53527902 | ||
| Inflammation as a matchmaker: revisiting cell fusion. | Q55049810 | ||
| Stem-cell fusion: A twist of fate | Q59077524 | ||
| The making of a vesicle | Q59096956 | ||
| IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells | Q61976682 | ||
| Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis | Q73289688 | ||
| Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates | Q78654754 | ||
| HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells | Q79149793 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Purkinje cell | Q1570272 |
| P304 | page(s) | 166-178 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
| P1476 | title | Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells | |
| P478 | volume | 37 |
| Q51733772 | Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells. |
| Q50502635 | Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis. |
| Q35648004 | Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion |
| Q53435286 | Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice. |
| Q28082334 | Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy |
| Q27691973 | Cell fusion in the brain: two cells forward, one cell back. |
| Q47619959 | Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases |
| Q26745447 | Cell-cell fusion in the nervous system: Alternative mechanisms of development, injury, and repair |
| Q35001739 | Cellular fusion for gene delivery to SCA1 affected Purkinje neurons |
| Q33843083 | Cerebellar Dysfunction in Multiple Sclerosis |
| Q38150823 | Disease modification in multiple sclerosis: an update |
| Q26752137 | Experimental neurotransplantation treatment for hereditary cerebellar ataxias |
| Q36179233 | Fusion of Human Fetal Mesenchymal Stem Cells with "Degenerating" Cerebellar Neurons in Spinocerebellar Ataxia Type 1 Model Mice. |
| Q35603241 | Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis |
| Q33900760 | Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells |
| Q84606936 | Human mesenchymal stem cells increase anti-oxidant defences in cells derived from patients with Friedreich's ataxia |
| Q51009747 | Hypoxic stress and IL-7 gene overexpression enhance the fusion potential of rat bone marrow mesenchymal stem cells with bovine renal epithelial cells. |
| Q53608103 | Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis. |
| Q38957213 | Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model. |
| Q92650424 | Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application |
| Q34053510 | Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts |
| Q38065844 | Mesenchymal stem cells/multipotent mesenchymal stromal cells (MSCs): potential role in healing cutaneous chronic wounds |
| Q47215124 | Myogenic potential of mesenchymal stem cells isolated from porcine adipose tissue. |
| Q30590258 | Primary progressive multiple sclerosis: progress and challenges. |
| Q48378074 | Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum |
| Q42766637 | Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia |
| Q39448729 | Recovery of fertility in azoospermia rats after injection of adipose-tissue-derived mesenchymal stem cells: the sperm generation |
| Q38897803 | Stem Cell Therapy for the Central Nervous System in Lysosomal Storage Diseases |
| Q41472176 | Stem cell models of polyglutamine diseases and their use in cell-based therapies |
| Q90296110 | The effects of transplanted mesenchymal stem cells treated with 17-b estradiol on experimental autoimmune encephalomyelitis |
| Q37982954 | The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis. |
Search more.